Global Bioenergies’ (GBE) acquisition of Syngip in an all-share deal further strengthens the company’s third-generation processes and as such is very synergistic. Our valuation range is now €34-51 per share (from €37-56) due to the higher share count.
Written by
Global Bioenergies |
Synergistic acquisition for new markets |
Trading update |
Alternative energy |
8 March 2017 |
Share price performance
Business description
Next events
Analysts
Global Bioenergies is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||||
Global Bioenergies’ (GBE) acquisition of Syngip in an all-share deal further strengthens the company’s third-generation processes and as such is very synergistic. Our valuation range is now €34-51 per share (from €37-56) due to the higher share count.
Year |
Revenue (€m) |
PBT* |
EPS* |
DPS |
P/E |
Yield |
12/14 |
3.2 |
(9.2) |
(2.9) |
0.0 |
N/A |
N/A |
12/15 |
2.2 |
(12.2) |
(4.0) |
0.0 |
N/A |
N/A |
12/16e |
2.2 |
(12.1) |
(3.4) |
0.0 |
N/A |
N/A |
12/17e |
4.4 |
(10.9) |
(2.7) |
0.0 |
N/A |
N/A |
Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.
Synergistic acquisition of international start-up
GBE has acquired Syngip, a Dutch start-up that is developing a process based on microorganisms to produce light olefins. The company uses industrial waste emissions in order to convert carbon monoxide (CO) and carbon dioxide (CO2) through metabolisation. GBE will incorporate metabolic pathways in order to produce isobutene as a first output product, thus the process is in direct synergy with GBE’s product. In terms of both the product and the expansion of technology, Syngip fits very well into GBE’s strategy to expand into third-generation processes. We understand that Syngip will continue to focus on further developing third-generation processes. This is important to broaden feedstock sources, and because they enable GBE to reduce its cost base and its dependency on the commodity spread between oil and sugar prices. Syngip’s process is expected to be competitive with the conventional olefins production process at an oil price of US$45/bbl. Taking into account renewable fuel incentives, the break-even oil price will be still lower. It is also noteworthy that the Syngip process contributes to GHG emission savings, which positions GBE as a solution for industrial companies looking to comply with increasingly tight emissions regulations. We also note that this acquisition further widens the international reach of the company.
Share-based deal with incentives
GBE will acquire Syngip in an all-share deal and issue 37,240 new shares and 61,191 warrants. Exercise of the warrants is subject to Syngip achieving technology development milestones by February 2019. With that, management estimates c 1.1% dilution for existing shareholders, which could increase to a maximum of 3.1% after exercise of all warrants. In this way, the company conserves cash, which it will require for organic growth, and also ensures there is incentive for technology success. The deal values Syngip at €875k. There is a lockup period on the new shares until the milestone is reached or until February 2019.
Valuation: €34-51/share
We value GBE on a DCF methodology with risk-weighted cash flows to reflect the early-stage nature of the business. Our valuation range reduces from €37-56/share to €34-51 on a higher share count. Further progress on new feedstock development, reinforced by Syngip’s acquisition, might reduce GBE’s dependence on commodities prices.
Widened market reach
GBE is developing a process based on three generations of feedstocks for isobutene production. Besides fuel production, each generation targets particular markets for the company. Each of those provides benefits of sectoral and geographic diversification, enhanced commercial development potential and reduction of dependence on commodities.
■
The first-generation technology is based on sugar beets. It targets the agricultural economy. The sugar industry and other agricultural sectors are initial potential commercial licensees. Europe and the US, but also tropical regions and particularly Brazil are key regions.
■
Second-generation feedstocks are mostly wood and forestry based. Forestry and paper industries in Northern Europe are key markets. The technology also reduces feedstock costs.
■
The third-generation technology uses the combination of CO and CO2. Steel manufacturers are the most immediate target market as they produce large quantities of unabated emissions in the CO/CO2 combination. The development of the third generation therefore opens the technology to additional industries and also new geographies: Germany, Eastern Europe and China are very important region for the steel sector.
The Syngip deal therefore provides additional diversification and opens new markets, while the company will continue to target its first- and second-generation based industries and regions. This is particularly relevant as the company needs to develop markets where it can be commercially successful in a low oil price environment.
Exhibit 1: Financial summary
€m |
2013 |
2014 |
2015 |
2016e |
2017e |
||
Year end 31 December |
FGAAP |
FGAAP |
FGAAP |
FGAAP |
FGAAP |
||
PROFIT & LOSS |
|||||||
Grants |
0.03 |
1.36 |
0.86 |
1.20 |
0.90 |
||
Other revenue |
2.43 |
1.81 |
1.37 |
1.00 |
3.50 |
||
Revenue |
|
|
2.46 |
3.17 |
2.23 |
2.20 |
4.40 |
Operating Expenses |
(6.36) |
(7.85) |
(6.97) |
(7.49) |
(7.82) |
||
Gross Profit |
(3.90) |
(4.69) |
(4.75) |
(5.29) |
(3.42) |
||
EBITDA |
(6.55) |
(8.99) |
(11.04) |
(10.60) |
(8.82) |
||
Operating Profit (before amort. and except.) |
|
(6.66) |
(9.50) |
(12.01) |
(11.67) |
(10.42) |
|
Amortisation |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
||
Exceptionals |
(0.00) |
0.00 |
0.11 |
0.00 |
0.00 |
||
Other |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
||
Operating Profit |
(6.67) |
(9.50) |
(11.90) |
(11.67) |
(10.42) |
||
Net Interest |
0.13 |
0.29 |
(0.26) |
(0.45) |
(0.50) |
||
Profit Before Tax (norm) |
|
|
(6.54) |
(9.21) |
(12.16) |
(12.12) |
(10.92) |
Tax |
1.41 |
1.59 |
1.99 |
1.60 |
1.65 |
||
Minority interests |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
||
Net income (Adj NP) |
(5.12) |
(7.62) |
(10.29) |
(10.53) |
(9.27) |
||
Net income (Reported) |
(5.12) |
(7.62) |
(10.18) |
(10.53) |
(9.27) |
||
Average Number of Shares Outstanding (m) |
2.5 |
2.6 |
2.6 |
3.1 |
3.4 |
||
EPS - normalised fully diluted (c) |
|
|
(204.82) |
(293.11) |
(395.61) |
(334.68) |
(272.67) |
EPS - (Reported) (c) |
|
|
(2.05) |
(2.93) |
(3.91) |
(3.35) |
(2.73) |
Gross Margin (%) |
N/A |
N/A |
N/A |
N/A |
N/A |
||
EBITDA Margin (%) |
N/A |
N/A |
N/A |
N/A |
N/A |
||
Operating Margin (before GW and except.) (%) |
N/A |
N/A |
N/A |
N/A |
N/A |
||
BALANCE SHEET |
|||||||
Fixed Assets |
|
|
1.76 |
3.97 |
7.43 |
11.68 |
12.52 |
Intangible Assets |
0.09 |
0.14 |
0.11 |
0.11 |
0.11 |
||
Tangible Assets |
1.58 |
3.72 |
7.18 |
11.43 |
12.27 |
||
Investments |
0.09 |
0.11 |
0.14 |
0.14 |
0.14 |
||
Current Assets |
|
|
25.72 |
20.65 |
14.78 |
9.78 |
9.39 |
Stocks |
2.02 |
0.29 |
0.30 |
0.21 |
0.21 |
||
Debtors |
0.00 |
0.00 |
0.34 |
0.52 |
0.94 |
||
Cash |
23.70 |
15.66 |
10.42 |
5.33 |
4.50 |
||
Other |
0.00 |
4.71 |
3.73 |
3.73 |
3.73 |
||
Current Liabilities |
|
|
(0.72) |
(2.40) |
(3.18) |
(1.21) |
(1.93) |
Creditors |
(0.72) |
(2.40) |
(3.18) |
(1.21) |
(1.93) |
||
Short term borrowings |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
||
Long Term Liabilities |
|
|
(3.74) |
(5.64) |
(11.10) |
(11.13) |
(11.13) |
Long term borrowings |
(2.46) |
(4.16) |
(10.44) |
(10.44) |
(10.44) |
||
Other long term liabilities |
(1.28) |
(1.48) |
(0.66) |
(0.69) |
(0.69) |
||
Net Assets |
|
|
23.02 |
16.58 |
7.93 |
9.12 |
8.85 |
CASH FLOW |
|||||||
Operating Cash Flow |
|
|
(4.33) |
(8.01) |
(8.84) |
(11.51) |
(7.38) |
Net Interest |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
||
Tax |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
||
Capex |
(0.79) |
(2.80) |
(4.49) |
(5.33) |
(2.44) |
||
Acquisitions/disposals |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
||
Financing |
21.73 |
1.07 |
1.81 |
11.75 |
9.00 |
||
Dividends |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
||
Net Cash Flow |
16.62 |
(9.74) |
(11.52) |
(5.09) |
(0.82) |
||
Opening net debt/(cash) |
|
|
(4.62) |
(21.24) |
(11.50) |
0.02 |
5.11 |
Other |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
||
FX adjustments |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
||
Closing net debt/(cash) |
|
|
(21.24) |
(11.50) |
0.02 |
5.11 |
5.94 |
Source: Global Bioenergies accounts, Edison Investment Research. Note: 2016/17 financing includes convertible funding, which was modelled as an equity transaction assuming the conversion price of €25/share. We assume that three tranches are exercised in 2016 and the remainder in 2017.
|
|
Research: TMT
XP Power has successfully transitioned its business and now designs and manufactures the majority of the products it sells. To reflect this achievement, management has refined its strategy to focus on maintaining its competitive position, increasing penetration of its existing customer base and targeting new high-value customers. With strong cash flow generation, the company has the resources to fund growth, whether through internal product development or via acquisition.